Objective To investigate the expression of miRNA-140 in chondrocytes and synovial fluid of osteoarthritis(OA) patients, and explore the relationship between the miRNA-140 expression and OA severity. Methods This study...Objective To investigate the expression of miRNA-140 in chondrocytes and synovial fluid of osteoarthritis(OA) patients, and explore the relationship between the miRNA-140 expression and OA severity. Methods This study enrolled 30 OA patients who underwent total knee arthroplasty for chondrocytes sampling and 30 OA patients who underwent intra-articular injection for synovial fluid sampling. All OA patients were grouped into mild [Kellgren and Lawrence(KL) grade 1-2], moderate(KL grade 3) and severe(KL grade 4), with 10 in each subgroups for each sampling purposes. 7 non-OA patients and 10 patients with knee injury were collected for cartilage and synovial fluid sampling respectively as control groups. Chondrocytes were isolated from the cartilage tissue and cultured in vitro. Quantitative real time PCR for miRNA-140 in chondrocytes and synovial fluid were performed, and the U6 sn RNA was used as internal control. The expression difference of miRNA-140 among groups and correlation between the expression and the KL grade of OA were analysed using one-way ANOVA and Spearman test respectively. Results The expression of miRNA-140 in chondrocytes of knees in OA patients was reduced than that in normal knees, and the between-group difference was statistically significant(F=305.464, P<0.001). miRNA-140 could be detected in synovial fluid of both normal knees and OA knees, its relative expression level was reduced in synovial fluid of OA group compared with normal group, and the between-group difference was statistically significant as well(F=314.245, P<0.001). The relative expression level of miRNA-140 in both chondrocytes and synovial fluid were negatively correlated with the KL grade of OA(r=-0.969, P<0.001; r=-0.970, P<0.001). Conclusion miRNA-140 could be detected in chondrocytes and synovial fluid of OA patients, and its expression was negatively correlated with the severity of OA.展开更多
AIM： To investigate the damaging effect of high-intensity focused ultrasound （HIFU） on cancer cells and the inhibitory effect on tumor growth. METHODS： Hurine H22 hepatic cancer cells were treated with HIFU at the...AIM： To investigate the damaging effect of high-intensity focused ultrasound （HIFU） on cancer cells and the inhibitory effect on tumor growth. METHODS： Hurine H22 hepatic cancer cells were treated with HIFU at the same intensity for different lengths of time and at different intensities for the same length oftime in vitro, the dead cancer cells were determined by trypan blue staining. Two groups of cancer cells treated with HIFU at the lowest and highest intensity were inoculated into mice. Tumor masses were removed and weighed after 2 wk, tumor growth in each group was confirmed pathologically.RESULTS： The death rate of cancer cells treated with HIFU at 1 000 W/cm^2 for 0.5, 1, 2, 4, 8, and 12 s was 3.11±1.21%, 13.37±2.56%, 38.84±3.68%, 47.22±5.76%,87.55±7.32%, and 94.33±8.11%, respectively. A positive relationship between the death rates of cancer cells and the length of HIFU treatment time was found （r = 0.96,P〈0.01）. The death rate of cancer cells treated with HIFU at the intensity of 100, 200, 400, 600, 800, and 1 000 W/cm^2 for 8 s was 26.31±3.26%, 31.00±3.87%, 41.97±5.86%,72.23±8.12%, 94.90±8.67%, and 99.30±9.18%, respectively. A positive relationship between the death rates of cancer cells and the intensities of HIFU treatment was confirmed （r= 0.98, P〈0.01）. The cancer cells treated with HIFU at 1 000 W/cm^2 for 8 s were inoculated intomice ed into. The tumor inhibitory rate was 90.35% compared to the control （P〈0.01）. In the experimental group inoculated with the cancer cells treated with HIFU at 1 000 W/cm^2 for 0.5 s, the tumor inhibitory rate was 22.9% （P〈0.01）. By pathological examination, tumor growth was confirmed in 8 out of 14 mice （57.14%, 8/14） inoculated with the cancer cells treated with HIFU at 1 000 W/cm^2 for 8 s, which was significantly lower than that in the control （100%, 15/15, P〈O.05）.CONCLUSION： HIFU is effective on killing or damage of H22 hepatic cancer cells in vitro and on inhibiting tumor growth in mice ex vivo.展开更多
Traumatic brain injury (TBI) represents a major global health challenge due to its complex pathophysiology and long-term neurological sequelae.Current treatments are insufficient to promote neural repair and functiona...Traumatic brain injury (TBI) represents a major global health challenge due to its complex pathophysiology and long-term neurological sequelae.Current treatments are insufficient to promote neural repair and functional recovery,highlighting the urgent need for innovative strategies.Biomaterial-based approaches have emerged as transformative solutions,offering new possibilities for TBI treatment and cranial repair.This review explores the role of extracellular matrix (ECM) simulation in TBI repair,emphasizing ECM-inspired biomaterials that replicate natural microenvironments to support cell adhesion,migration,and differentiation.Advanced biomaterials regulate cell behavior through biophysical and biochemicalcues,enhancing neural regeneration.Strategies for activating key signaling pathways,such as PI3K/Akt and Nrf2/HO-1,are discussed,showing how biomaterials promote neuroprotection,reduce inflammation,and support tissue repair.The review also highlights the potential of 3D printing technology to design personalized scaffolds to address TBI repair's structural and functional complexities.Finally,neural interfaces are presented as cutting-edge bioelectronic systems that integrate with neural tissues,reducing mechanical mismatch and promoting functional recovery.These interfaces provide a platform for precise neural stimulation and real-time monitoring.By integrating ECM simulation,advanced biomaterials,3D printing,and neural interfaces,this review provides a comprehensive framework for addressing the challenges of TBI repair.These innovations hold promise for developing personalized,next-generation therapies to improve patient outcomes and advance regenerative medicine.Future researchshould focus on developing dynamic,intelligent biomaterials,advancing 3D printing for precise tissue reconstruction,and integrating biomaterials with gene and drug therapies to create personalized,multi-faceted treatment approaches for traumatic brain injury repair.展开更多
基金Supported by the National Natural Science Foundation of China(No.81672219No.81601936)the Science and Technology Support Program of Sichuan province(No.2014SZ0023-2)
文摘Objective To investigate the expression of miRNA-140 in chondrocytes and synovial fluid of osteoarthritis(OA) patients, and explore the relationship between the miRNA-140 expression and OA severity. Methods This study enrolled 30 OA patients who underwent total knee arthroplasty for chondrocytes sampling and 30 OA patients who underwent intra-articular injection for synovial fluid sampling. All OA patients were grouped into mild [Kellgren and Lawrence(KL) grade 1-2], moderate(KL grade 3) and severe(KL grade 4), with 10 in each subgroups for each sampling purposes. 7 non-OA patients and 10 patients with knee injury were collected for cartilage and synovial fluid sampling respectively as control groups. Chondrocytes were isolated from the cartilage tissue and cultured in vitro. Quantitative real time PCR for miRNA-140 in chondrocytes and synovial fluid were performed, and the U6 sn RNA was used as internal control. The expression difference of miRNA-140 among groups and correlation between the expression and the KL grade of OA were analysed using one-way ANOVA and Spearman test respectively. Results The expression of miRNA-140 in chondrocytes of knees in OA patients was reduced than that in normal knees, and the between-group difference was statistically significant(F=305.464, P<0.001). miRNA-140 could be detected in synovial fluid of both normal knees and OA knees, its relative expression level was reduced in synovial fluid of OA group compared with normal group, and the between-group difference was statistically significant as well(F=314.245, P<0.001). The relative expression level of miRNA-140 in both chondrocytes and synovial fluid were negatively correlated with the KL grade of OA(r=-0.969, P<0.001; r=-0.970, P<0.001). Conclusion miRNA-140 could be detected in chondrocytes and synovial fluid of OA patients, and its expression was negatively correlated with the severity of OA.
基金Supported by the Grant from National Economic Trade Committee, No. 2000-312-2
文摘AIM： To investigate the damaging effect of high-intensity focused ultrasound （HIFU） on cancer cells and the inhibitory effect on tumor growth. METHODS： Hurine H22 hepatic cancer cells were treated with HIFU at the same intensity for different lengths of time and at different intensities for the same length oftime in vitro, the dead cancer cells were determined by trypan blue staining. Two groups of cancer cells treated with HIFU at the lowest and highest intensity were inoculated into mice. Tumor masses were removed and weighed after 2 wk, tumor growth in each group was confirmed pathologically.RESULTS： The death rate of cancer cells treated with HIFU at 1 000 W/cm^2 for 0.5, 1, 2, 4, 8, and 12 s was 3.11±1.21%, 13.37±2.56%, 38.84±3.68%, 47.22±5.76%,87.55±7.32%, and 94.33±8.11%, respectively. A positive relationship between the death rates of cancer cells and the length of HIFU treatment time was found （r = 0.96,P〈0.01）. The death rate of cancer cells treated with HIFU at the intensity of 100, 200, 400, 600, 800, and 1 000 W/cm^2 for 8 s was 26.31±3.26%, 31.00±3.87%, 41.97±5.86%,72.23±8.12%, 94.90±8.67%, and 99.30±9.18%, respectively. A positive relationship between the death rates of cancer cells and the intensities of HIFU treatment was confirmed （r= 0.98, P〈0.01）. The cancer cells treated with HIFU at 1 000 W/cm^2 for 8 s were inoculated intomice ed into. The tumor inhibitory rate was 90.35% compared to the control （P〈0.01）. In the experimental group inoculated with the cancer cells treated with HIFU at 1 000 W/cm^2 for 0.5 s, the tumor inhibitory rate was 22.9% （P〈0.01）. By pathological examination, tumor growth was confirmed in 8 out of 14 mice （57.14%, 8/14） inoculated with the cancer cells treated with HIFU at 1 000 W/cm^2 for 8 s, which was significantly lower than that in the control （100%, 15/15, P〈O.05）.CONCLUSION： HIFU is effective on killing or damage of H22 hepatic cancer cells in vitro and on inhibiting tumor growth in mice ex vivo.
基金financially supported by the Natural Science Foundation of Sichuan(No.2022NSFSC1474)Sichuan Administration of Traditional Chinese Medicine Research Special Foundation(No.2024zd034)
文摘Traumatic brain injury (TBI) represents a major global health challenge due to its complex pathophysiology and long-term neurological sequelae.Current treatments are insufficient to promote neural repair and functional recovery,highlighting the urgent need for innovative strategies.Biomaterial-based approaches have emerged as transformative solutions,offering new possibilities for TBI treatment and cranial repair.This review explores the role of extracellular matrix (ECM) simulation in TBI repair,emphasizing ECM-inspired biomaterials that replicate natural microenvironments to support cell adhesion,migration,and differentiation.Advanced biomaterials regulate cell behavior through biophysical and biochemicalcues,enhancing neural regeneration.Strategies for activating key signaling pathways,such as PI3K/Akt and Nrf2/HO-1,are discussed,showing how biomaterials promote neuroprotection,reduce inflammation,and support tissue repair.The review also highlights the potential of 3D printing technology to design personalized scaffolds to address TBI repair's structural and functional complexities.Finally,neural interfaces are presented as cutting-edge bioelectronic systems that integrate with neural tissues,reducing mechanical mismatch and promoting functional recovery.These interfaces provide a platform for precise neural stimulation and real-time monitoring.By integrating ECM simulation,advanced biomaterials,3D printing,and neural interfaces,this review provides a comprehensive framework for addressing the challenges of TBI repair.These innovations hold promise for developing personalized,next-generation therapies to improve patient outcomes and advance regenerative medicine.Future researchshould focus on developing dynamic,intelligent biomaterials,advancing 3D printing for precise tissue reconstruction,and integrating biomaterials with gene and drug therapies to create personalized,multi-faceted treatment approaches for traumatic brain injury repair.
